CNR1 and schizophrenia: Consistent with this clinical data, we and others have previously demonstrated in rodent neurodevelopmental models that adolescent exposure to THC or other CB1R agonists produce several behavioral abnormalities persisting into adulthood, similar to symptoms observed in psychiatric diseases, notably schizophrenia.